Related references
Note: Only part of the references are listed.Background, rationale, and design of a clinical trial to assess the effects of platelet dose on bleeding risk in thrombocytopenic patients
SJ Slichter
JOURNAL OF CLINICAL APHERESIS (2006)
Platelet transfusion prophylaxis for patients with haematological malignancies: where to now?
SJ Stanworth et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
The influence of various hematology analyzers on component platelet counts
G Moroff et al.
TRANSFUSION MEDICINE REVIEWS (2005)
Accuracy of platelet counting haematology analysers in severe thrombocytopenia and potential impact on platelet transfusion
HC Segal et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
The efficiency of transfusing high doses of platelets in hematologic patients with thrombocytopenia:: results of a prospective, randomized, open, blinded end point (PROBE) study
L Sensebé et al.
BLOOD (2005)
The platelet count accuracy of platelet concentrates obtained by using automated analysis is influenced by instrument bias and activated platelet components
T Hervig et al.
VOX SANGUINIS (2004)
Therapeutic efficacy and safety of platelets treated with a photochemical process for pathogen inactivation: the SPRINT Trial
J McCullough et al.
BLOOD (2004)
Relationship between platelet count and bleeding risk in thrombocytopenic patients
SJ Slichter
TRANSFUSION MEDICINE REVIEWS (2004)
Prophylactic platelet transfusions: Which dose is the best dose? A review of the literature
AT Tinmouth et al.
TRANSFUSION MEDICINE REVIEWS (2003)
Prophylactic platelet transfusions from healthy apheresis platelet donors undergoing treatment with thrombopoietin
LT Goodnough et al.
BLOOD (2001)
Share Paper
